Recombinant Human Granulocyte Colony-stimulating Factor Injection

KYOWA KIRIN CO., LTD.🇨🇳 National Medical Products Administration

Approval Id: e8ea62b07fcf57e1
Approval Number: 国药准字SJ20171033
Generic Name: 重组人粒细胞刺激因子注射液
Generic Name En: Recombinant Human Granulocyte Colony-stimulating Factor Injection
Trade Name: 惠尔血
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 75μg/0.3ml/支
Reg Date: 2022-08-10
Expired Date: 2027-08-09
Company Name: KYOWA KIRIN CO., LTD.
Company Detail Path: /organization/kyowa-kirin-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 10, 2022

Approval ID

e8ea62b07fcf57e1

Type

生物制品